Bertrand Vannier

Bertrand Vannier has had a diverse range of work experience spanning several industries. Bertrand currently serves as the Senior Director of Finance at Mnemo Therapeutics, a biotech company specializing in immuno-oncology. Prior to this role, they were the Chief Financial Officer at Business Table, a SaaS booking platform, and at Yoopala Services, a high-growth company in the services industry. Bertrand also held the position of Chief Financial Officer at Cytheris, a biotech company, and Unither Pharmaceuticals, a company held by LBO funds. At Unither Pharmaceuticals, they were a member of the executive committee and supervised the accounting and finance departments. Before that, Bertrand worked at FFT Equity - Avenir finance as a Chargé d'affaires en Corporate Finance and at Vivendi Universal as a Chargé de mission. Bertrand began their career as an auditor at Ernst & Young.

Bertrand Vannier completed a Diploma Program in Finance at the University of California, Berkeley in 1998. In 1989 to 1990, they pursued a Diplôme d’Etudes Comptables et Financières (DECF) at an institution called DECF, specializing in accounting, tax, legal, and financial analysis. Prior to that, from 1985 to 1988, they obtained a Diploma in Economics and Finance from Sciences Po.